You are currently viewing a new version of our website. To view the old version click .

The Quest for Novel Antimicrobials: From Chemical Synthesis and Discovery to Mechanisms of Action and Resistance

Special Issue Information

Dear Colleagues,

The ongoing worldwide viral pandemic that is affecting all of us highlights the problem of microbial resistance to available drugs and the urgent need for the development of novel antibacterial, antifungal and antiviral compounds. The current rush for the development of antivirals and vaccines to control SARS-COV2 points out the need for the research of novel antifungal and antibacterial compounds to cope with established pathogens and emerging multiresistant strains. In recent years, research laboratories and academia have taken the front edge of research on antimicrobials, as the introduction of novel antibiotics into the market has continuously declined.

This Special Issue aims to gather papers describing novel antimicrobial molecules that are active against bacteria, fungi and viruses, originating from chemical synthesis, repositioning of existent drugs, or from natural sources, like plants, herbs and spices extracts. We are also welcoming papers describing the discovery of novel targets and mechanisms of action and resistance, as well as on the use of omics and bioinformatic approaches to advance the field of novel antimicrobials discovery.

Prof. Jorge H. Leitão
Dr. Luis G. Alves
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antibacterial
  • antifungal
  • antiviral
  • new synthetic routes
  • drug discovery
  • mechanisms of action
  • antimicrobial resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382Creative Common CC BY license